Dare Bioscience, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-20.
Dare Bioscience, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 20, 2026. Dare Bioscience, Inc. trades on Nasdaq as DARE; it was formerly Cerulean Pharma Inc. The filing reports $12.38M sold. Its industry group is Biotechnology. It names Sabrina Johnson (President and Chief Executive Officer), MarDee Haring-Layton (Chief Accounting Officer), William Rastetter (Director) (SEC Form D, August 20, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Dare Bioscience, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Dare Bioscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Dare Bioscience, Inc.
Free to see. No signup.
More on the people and the money behind Dare Bioscience, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in August 2026, largest first.
Get an email when Dare Bioscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Dare Bioscience, Inc. raises, hires or launches. No email unless you switch it on.
Watch Dare Bioscience, Inc. →Get the full cited report on Dare Bioscience, Inc.
What the filing shows about Dare Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Dare Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Dare Bioscience, Inc.'s address as 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Dare Bioscience, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Dare Bioscience, Inc. is a registered filer with the SEC (CIK 1401914) and has filed since 2023-12-26. 3 filings are on record, the latest on 2026-08-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Dare Bioscience, Inc.'s Form D of 2026-08-20 names Sabrina Johnson, MarDee Haring-Layton, William Rastetter and 4 more as its officers, directors or promoters.
Its new offerings report $14.11M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $12.38M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Sabrina Johnson is named as President and Chief Executive Officer on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
MarDee Haring-Layton is named as Chief Accounting Officer on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
William Rastetter is named as Director on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
Jessica Grossman is named as Director on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
Susan Kelley is named as Director on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
Gregory Matz is named as Director on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
Robin Steele is named as Director on the Form D that Dare Bioscience, Inc. filed with the SEC on 20 August 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-08-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Dare Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Dare Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dare Bioscience, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Dare Bioscience, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Dare Bioscience, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Dare Bioscience, Inc.. With no account yet, you sign up free and land on the result.
On these lists: San Diego raises, week of 2026-08-17 · Biotech raises, week of 2026-08-17 · Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/dare-bioscience-inc-form-d-26000001